Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 8861947 
This page summarizes selected information from the article referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Won KA, Reed SI (1996) Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15, 4182-93 8861947
Download Sites

T395-p - CCNE1 (human)
Orthologous residues
CCNE1 (human): T395‑p, CCNE1 (mouse): T393‑p
Characterization
 Methods used to characterize site in vivo [32P] bio-synthetic labeling, mutation of modification site, phosphoamino acid analysis, phosphopeptide mapping
 Relevant cell lines - cell types - tissues:  Rat1 (fibroblast)
 Cellular systems studied:  cell lines, primary cells
 Species studied:  rat, yeast
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE CDK2 (human)
Downstream Regulation
 Effect of modification (function):  protein degradation
 Effect of modification (process):  cell cycle regulation
 Comments:  T380 of cyclin E is necessary for for ubiquination and targeting to the proteosome.


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.